Similar articles for PMID: 35853738

Year	Number of Results
1999	1
2001	1
2003	1
2004	2
2005	2
2006	2
2007	2
2008	2
2009	4
2010	4
2011	1
2012	5
2013	6
2014	11
2015	9
2016	7
2017	11
2018	10
2019	8
2020	6
2021	5
2022	7
2023	2
2024	3

1

α-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?

Seibyl JP. Seibyl JP. J Nucl Med. 2022 Oct;63(10):1463-1466. doi: 10.2967/jnumed.122.263918. Epub 2022 Jul 19. J Nucl Med. 2022. PMID: 35853738 Free article. No abstract available.

2

α-synuclein imaging: a critical need for Parkinson's disease research.

Eberling JL, Dave KD, Frasier MA. Eberling JL, et al. J Parkinsons Dis. 2013;3(4):565-7. doi: 10.3233/JPD-130247. J Parkinsons Dis. 2013. PMID: 24192754 Free article.

3

Protocol for screening α-synuclein PET tracer candidates in vitro and ex vivo.

Xiang J, Xia Y, Luo S, Zhang Z, Ye K. Xiang J, et al. STAR Protoc. 2024 Mar 15;5(1):102788. doi: 10.1016/j.xpro.2023.102788. Epub 2023 Dec 19. STAR Protoc. 2024. PMID: 38117656 Free PMC article.

4

The role of neuroimaging in Parkinson's disease.

Bidesi NSR, Vang Andersen I, Windhorst AD, Shalgunov V, Herth MM. Bidesi NSR, et al. J Neurochem. 2021 Nov;159(4):660-689. doi: 10.1111/jnc.15516. Epub 2021 Oct 3. J Neurochem. 2021. PMID: 34532856 Free PMC article. Review.

5

In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging.

Verdurand M, Levigoureux E, Zeinyeh W, Berthier L, Mendjel-Herda M, Cadarossanesaib F, Bouillot C, Iecker T, Terreux R, Lancelot S, Chauveau F, Billard T, Zimmer L. Verdurand M, et al. Mol Pharm. 2018 Aug 6;15(8):3153-3166. doi: 10.1021/acs.molpharmaceut.8b00229. Epub 2018 Jul 25. Mol Pharm. 2018. PMID: 29989823

6

Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.

Phan JA, Stokholm K, Zareba-Paslawska J, Jakobsen S, Vang K, Gjedde A, Landau AM, Romero-Ramos M. Phan JA, et al. Sci Rep. 2017 Jul 25;7(1):6363. doi: 10.1038/s41598-017-06724-9. Sci Rep. 2017. PMID: 28743955 Free PMC article.

7

The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.

Xiong WX, Sun YM, Guan RY, Luo SS, Chen C, An Y, Wang J, Wu JJ. Xiong WX, et al. J Neurol. 2016 Oct;263(10):1984-92. doi: 10.1007/s00415-016-8213-1. Epub 2016 Jul 8. J Neurol. 2016. PMID: 27393118 Review.

8

Association of plasma α-synuclein with cardiac ¹²³I-MIBG scintigraphy in early Parkinson's disease.

Park DG, Kang J, An YS, Chang J, Yoon JH. Park DG, et al. Neurosci Lett. 2022 Jan 23;770:136399. doi: 10.1016/j.neulet.2021.136399. Epub 2021 Dec 16. Neurosci Lett. 2022. PMID: 34921912

9

Positron emission tomography changes in PARK1 mutation.

Perani D, Garibotto V, Hadjigeorgiou GM, Papadimitriou D, Fazio F, Papadimitriou A. Perani D, et al. Mov Disord. 2006 Jan;21(1):127-30. doi: 10.1002/mds.20691. Mov Disord. 2006. PMID: 16211612 No abstract available.

10

(123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A.

Bostantjopoulou S, Katsarou Z, Gerasimou G, Costa DC, Gotzamani-Psarrakou A. Bostantjopoulou S, et al. Hell J Nucl Med. 2008 Sep-Dec;11(3):157-9. Hell J Nucl Med. 2008. PMID: 19081858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 35853738

95 results

Results by year